PRESENTATION
Metcela to Pitch at Investment Summit during BIO Asia-Taiwan 2026 | Metcela Inc.
Metcela Inc. , today announced that it has been invited to present at the Investment Summit program during BIO Asia-Taiwan 2026, held in Taipei, Taiwan, on July 15, 2026.
Metcela is dedicated to redefining the treatment paradigm for pediatric patients with congenital heart disease (CHD) utilizing its next-generation cell therapy pipeline, JRM-001. During the pitch presentation, the company will showcase the unique value of its proprietary technology, recent development milestones, and its strategic roadmap for global expansion.
■ Presentation Overview
Event Name: BIO Asia-Taiwan 2026 – Investment Summit
Date & Time: Wednesday, July 15, 2026, at 14:20 (Taiwan Standard Time / TST)
Venue: Room 701AB, 7F, TaiNEX 2, Taipei, Taiwan
Programme: Investment Summit